DSIP peptide nasal spray is a needle-free way to research delta sleep-inducing peptide. Learn reported dosages, delivery pros and cons, safety, and storage.
DSIP peptide nasal spray is a needle-free delivery format for delta sleep-inducing peptide, a nine-amino-acid peptide first isolated from rabbit brains in the 1970s. Researchers and self-experimenters use intranasal delivery because DSIP is broken down quickly in the stomach and bloodstream, and the nasal lining offers a faster route into circulation. DSIP is not FDA-approved for human use in the United States, so nasal sprays sold today are labeled as research chemicals only.
What Is Delta Sleep-Inducing Peptide?
Delta sleep-inducing peptide, usually shortened to DSIP, is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Swiss researchers isolated it in 1977 from the cerebral venous blood of rabbits after electrical stimulation of the thalamus, and the name came from the slow-wave "delta" activity seen on the animals' EEG recordings.
The peptide occurs naturally in mammals, including humans, and has been detected in the hypothalamus, pineal gland, and digestive tract. Natural circulating levels are extremely low, and peptidases in blood and tissue can clear DSIP within minutes. That short half-life is the main reason interest shifted toward routes of administration that avoid digestion.
Why Use a Nasal Spray Instead of Injections?
Intranasal delivery is the most common non-injection route studied for small peptides. The nasal epithelium is thin, highly vascular, and partially bypasses first-pass liver metabolism, which helps a peptide reach the bloodstream relatively quickly.
| Route | Absorption profile | Convenience | Research notes |
|---|---|---|---|
| Oral | Low; peptides are broken down by stomach acid and proteases | Easiest | Poor bioavailability expected |
| Intranasal | Rapid; partial bypass of first-pass metabolism | No needles required | Most popular non-injection route in research settings |
| Subcutaneous or IV | Near-complete absorption | Requires needles and sterile technique | Route used in the original human studies |
Injectable forms still deliver more predictable amounts, but many people prefer a spray for comfort and convenience. Nasal sprays also tend to last longer per vial because each dose is small.
Reported DSIP Nasal Spray Dosage in Research
There is no approved or standardized dosing schedule for DSIP in humans. Early clinical studies used intravenous infusions in the range of 25 to 50 micrograms per kilogram of body weight, while modern research-use sprays are typically described in micrograms per administration rather than per kilogram.
| Context | Reported amount | Typical timing |
|---|---|---|
| Early intravenous human studies | 25–50 mcg/kg | Single infusion before sleep monitoring |
| Research-use nasal spray (lower range) | 100–300 mcg | 30–60 minutes before bed |
| Research-use nasal spray (higher range) | 300–500 mcg | 30–60 minutes before bed |
| Reconstituted vials | Varies by dilution | Follow the supplier's certificate of analysis |
Because no approved dsip peptide dosage nasal spray exists, most published ranges come from animal work and older human trials rather than modern randomized studies. Many people searching for a dsip nasal spray dosage find only community reports and anecdotal logs rather than clinical guidance.
Anyone considering use should talk with a healthcare professional instead of copying a number from a forum post.
What the Research Actually Shows About Sleep
The human evidence for DSIP is thin. A small number of trials in the 1980s reported changes in sleep latency, sleep architecture, or subjective sleep quality, but results were inconsistent and sample sizes were tiny.
Animal studies have explored DSIP effects on stress hormones, pain signaling, and corticosterone release. Those findings are interesting, but they do not prove that a nasal spray improves sleep in healthy adults.
DSIP has never completed the large, placebo-controlled trials required for FDA approval as a sleep medication.
Purity, Sourcing, and Legal Status
DSIP is sold in the United States as a research chemical, not as a dietary supplement or a prescription drug. That means no federal review of identity, strength, sterility, or labeling.
- Ask for a third-party certificate of analysis showing HPLC purity of 98% or higher.
- Look for mass spectrometry confirmation of the correct peptide sequence.
- Avoid vendors that market the product for human consumption or promise a cure for insomnia.
Anyone hoping to buy dsip nasal spray should treat marketing claims with skepticism and verify supplier documentation before ordering.
Storage, Safety, and Related Peptides
Storage and handling basics
Lyophilized DSIP powder should be stored frozen or refrigerated and protected from light and moisture. Once reconstituted with bacteriostatic water, most research protocols keep the solution refrigerated at 2 to 8 degrees Celsius and use it within a few weeks.
Nasal spray devices should never be shared, and sterile technique matters when refilling them at home.
How it compares with other nasal peptides
Sleep-focused research often overlaps with other peptide categories. Weight-loss researchers sometimes compare it with aod-9604 peptide nasal spray, which targets fat metabolism rather than sleep architecture, and longevity-oriented compounds such as epitalon peptide nasal spray work through entirely different biological pathways.
Safety considerations
Human safety data for DSIP is limited, and long-term effects are unknown. People who are pregnant, breastfeeding, under 18, or taking sedatives, hypnotics, or anticoagulants should avoid research peptides unless a qualified clinician advises otherwise.
Reported short-term effects in the literature are generally mild, but nasal irritation, headache, and next-day grogginess are possible. None of this is medical advice, and a licensed healthcare professional is the right person to evaluate any ongoing sleep problem.
Frequently Asked Questions
Is DSIP peptide nasal spray FDA-approved?
No. DSIP is not approved by the FDA for human use in the United States, and nasal spray products sold online are labeled as research chemicals. Their purity, sterility, and strength are not verified by any regulator, and they cannot legally be marketed as a sleep aid or dietary supplement.
How is a DSIP nasal spray dosage typically chosen?
There is no standard human dose. Published trials used intravenous DSIP at roughly 25 to 50 micrograms per kilogram, while research-use nasal sprays are commonly described at 100 to 500 micrograms taken 30 to 60 minutes before bed. Those numbers come from anecdotal reports and older literature, not controlled modern studies.
What side effects have been reported with DSIP nasal spray?
Reported effects are usually mild and include nasal irritation, headache, and next-day drowsiness. Long-term safety data does not exist, and DSIP could theoretically interact with sedatives, sleep medications, and anticoagulants. Talk to a healthcare professional before using any research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.